83 related articles for article (PubMed ID: 6247830)
1. [The effect of glucagon on plasma adenosine cyclic-3'-5'-monophosphate in intrahepatic and extrahepatic cholestases].
Malinovská V; Rysánek K; Bílková B; Jahodová D
Vnitr Lek; 1980 Apr; 26(4):229-33. PubMed ID: 6247830
[No Abstract] [Full Text] [Related]
2. Glucagon-induced alterations of plasma levels of cyclic AMP and glucose in patients with liver disease.
Klotz U; Antonin KH
Z Gastroenterol; 1984 Mar; 22(3):147-52. PubMed ID: 6326401
[TBL] [Abstract][Full Text] [Related]
3. Glucagon stimulated plasma cyclic adenosine-3',5'-monophosphate in the differential diagnosis of jaundice.
Carstensen HE; Bruun E; Hansen OH; Marcussen H; Mollerup C
Surg Gynecol Obstet; 1979 Oct; 149(4):503-5. PubMed ID: 225837
[TBL] [Abstract][Full Text] [Related]
4. [Quantitative determination of lipoprotein-X (LP-X) in extrahepatic cholestasis and intrahepatic cholestasis].
Calvo C; Arroqui I
Rev Med Chil; 1984 Mar; 112(3):233-7. PubMed ID: 6473964
[No Abstract] [Full Text] [Related]
5. [The effect of thyroid function on the increase of plasma cyclic AMP following glucagon injection (author's transl)].
Jäckel W; Heimes J; Herrmann J
J Clin Chem Clin Biochem; 1980 Dec; 18(12):909-15. PubMed ID: 6259272
[TBL] [Abstract][Full Text] [Related]
6. Plasma cyclic adenosine-3', 5'-monophosphate response to glucagon in patients with liver disease.
Davies TF; Prudhoe K; Douglas AP
Br Med J; 1976 Apr; 1(6015):931-3. PubMed ID: 178399
[TBL] [Abstract][Full Text] [Related]
7. [Fibronectin and hepatic cholestasis].
Llena Puy MC; Cuesta Muñoz J; Muñoz y Fernández JR; Tres Sánchez A
Rev Clin Esp; 1984 Oct; 175(2):63-5. PubMed ID: 6522724
[No Abstract] [Full Text] [Related]
8. Plasma lecithin cholesterol acyl transferase activity, high density lipoprotein cholesterol and cholesterol ester in cholestasis.
Agbedana EO; Taylor GO; Olubuyide IO; Ahaneku JE
Afr J Med Med Sci; 1993 Sep; 22(3):41-4. PubMed ID: 7839911
[TBL] [Abstract][Full Text] [Related]
9. [Urinary cyclic AMP response to the administration of glucagon in diffuse hepatopathies and the effect of cholestasis on the same].
Díez Jarilla JL; González Macías J; Martín Rodríguez M
Med Clin (Barc); 1983 Oct; 81(13):564-6. PubMed ID: 6317998
[No Abstract] [Full Text] [Related]
10. [Clinical significance of plasma c-AMP response to glucagon in patients with cholestasis].
Kawai H; Kojima T; Kano T; Muto Y
Nihon Shokakibyo Gakkai Zasshi; 1984 Feb; 81(2):227-37. PubMed ID: 6325781
[No Abstract] [Full Text] [Related]
11. [Measurement of serum bile acids and correlation with various biological tests in the development of cholestasis].
Velo Bellver JL; Rabago Torre L; López Lazareno N; Fernández-Pacheco I; Caballero A; Menchen PL; López de la Riva M; Alcalá Santaella R
Rev Esp Enferm Apar Dig; 1982 Nov; 62(5):362-7. PubMed ID: 7167669
[No Abstract] [Full Text] [Related]
12. [Indices of blood lipid metabolism in cholestatic liver disease].
Labanovskaia ZhL
Lab Delo; 1981; (4):206-9. PubMed ID: 6164851
[No Abstract] [Full Text] [Related]
13. [Effect of glucagon on plasma levels of 3',5'-adenosine monophosphate in patients with liver cirrhosis (author's transl)].
Malinovská V; Rysánek K; Bílková B; Martínek K; Ochmanová D
Cas Lek Cesk; 1977 Jul; 116(27):850-3. PubMed ID: 198133
[No Abstract] [Full Text] [Related]
14. Impaired plasma cyclic AMP response to exogenous glucagon in acute liver injury.
Miyakoshi H; Noda Y; Uchida S; Tanaka N; Noto Y; Kato Y; Kawai K; Hayakawa H; Kobayashi K; Hattori N
J Clin Gastroenterol; 1984 Aug; 6(4):337-42. PubMed ID: 6090530
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein X in the cholestatic syndrome.
Vrublovský P; Kubícek R; Seidlová V; Smoldas J; Zák J
Acta Univ Palacki Olomuc Fac Med; 1988; 119():423-6. PubMed ID: 2977506
[No Abstract] [Full Text] [Related]
16. Serum cystatin C measurement in differential diagnosis of intra and extrahepatic cholestatic diseases.
Buyukberber M; Koruk I; Cýkman O; Koruk M; Küçükoglu ME; Sakman A; Demir O; Sahinoz S
Ann Hepatol; 2010; 9(1):58-62. PubMed ID: 20332548
[TBL] [Abstract][Full Text] [Related]
17. Effect of glucagon infusion on blood glucose, plasma immunoreactive insulin, growth hormone and adenosine 3'5'-monophosphate in obese children.
Molnár D; Kardos M; Soltész G
Acta Paediatr Acad Sci Hung; 1981; 22(4):325-9. PubMed ID: 6282041
[TBL] [Abstract][Full Text] [Related]
18. [Lipoprotein-X as an indicator of cholestasis in liver and biliary tract diseases].
Sawaryn T
Wiad Lek; 1984 Oct; 37(19):1522-7. PubMed ID: 6396957
[No Abstract] [Full Text] [Related]
19. Double-blind placebo-controlled clinical trial of microporous cholestyramine in the treatment of intra- and extra-hepatic cholestasis: relationship between itching and serum bile acids.
Di Padova C; Tritapepe R; Rovagnati P; Rossetti S
Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):773-6. PubMed ID: 6397677
[TBL] [Abstract][Full Text] [Related]
20. [Urinary cAMP excretion after glucagon administration to patients with diseases of the liver and bile ducts ].
Díez Jarilla JL; González Macías J; Martín Rodríguez M; Laso Guzmán FJ
Med Clin (Barc); 1982 Jun 16-30; 79(2):74-6. PubMed ID: 6289023
[No Abstract] [Full Text] [Related]
[Next] [New Search]
